What is the brand name for Sitagliptin?
The brand name for Sitagliptin is Januvia.
Januvia
Sitagliptin is the generic name for the brand-name drug Januvia. It is a dpp-4 inhibitor used to treat type 2 diabetes. On the PTCE Top 200 drug list, Sitagliptin ranks #123 and is one of the most frequently tested endocrine/diabetes medications — commonly quizzed on its brand–generic pair, drug class, and key side effects.
| Generic name | Sitagliptin |
|---|---|
| Brand name(s) | Januvia |
| Drug class | DPP-4 inhibitor |
| Class group | Endocrine/Diabetes |
| Common use | type 2 diabetes |
| DEA schedule | Unscheduled |
| Availability | Prescription only (Rx) |
Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (alone or with other antidiabetic agents).
Sitagliptin is a DPP-4 inhibitor in the Endocrine/Diabetes group. Knowing the class is the fastest way to predict its uses, side effects, and the brand↔generic pairs the PTCE tests.
No. Sitagliptin is not a federally controlled substance (it is unscheduled by the DEA).
The suffix -gliptin = a DPP-4 inhibitor. Like metformin, sitagliptin rarely causes lows on its own — and Januvia vs Janumet (adds metformin) is the combo-product angle.
The brand name for Sitagliptin is Januvia.
Sitagliptin is used to treat type 2 diabetes. Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (alone or with other antidiabetic agents).
Sitagliptin is a DPP-4 inhibitor (Endocrine/Diabetes group).
No. Sitagliptin is not a federally controlled substance (it is unscheduled by the DEA).
RxReflex turns the Top 200 drugs into fast flashcard rounds, a guided Learn path, pharmacy math, and 40+ cheat sheets. Free to start.
Last reviewed June 25, 2026. Educational use only — not medical advice. Verify clinical specifics with your pharmacist or a current label source such as DailyMed. RxReflex is not affiliated with or endorsed by the Pharmacy Technician Certification Board (PTCB).